Delivery Order SPE2DB22D2007-SPE2DB23FJ3KB
Award Date 6/20/23
Potential Completion Date 6/21/23
Potential Value $439
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $439,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561288641, which is described as Docetaxel 160 MG/8 ML VIAL 8ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning from June 20, 2023 to June 21, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports...
- The Defense Logistics Agency awarded a $64,170 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561339212 DOCETAXEL 160 MG/8 ML VIAL 8ML. As a prime contractor for pharmaceutical products, Amerisourcebergen will supply the anticancer medication docetaxel to the DLA, which manages the Department of Defense's global logistics operations. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from...
- The Defense Logistics Agency awarded a $64,170 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561339219 DOCETAXEL 160 MG/8 ML VIAL 8ML pharmaceutical products. As the prime contractor, Amerisourcebergen will deliver the chemotherapy drugs from its Conshohocken, Pennsylvania facility to support the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were identified in the award information. The delivery order...
- The Defense Logistics Agency awarded a $31,090 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561569135 DOCETAXEL 80 MG/4 ML VIAL 4ML. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and will provide chemotherapy drugs to DLA and Department of Defense customers through July 24, 2023. Performance will take place at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania, with no subcontractors involved. The...
- The Defense Logistics Agency awarded a $3,264 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562299367 DOCETAXEL 80 MG/8 ML VIAL 8ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania under a one-day period of performance beginning and ending on September 25-26, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations,...
- The Defense Logistics Agency awarded a $3,264 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4562143244 DOCETAXEL 80 MG/8 ML VIAL 8ML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements. The parent company, Amerisourcebergen Corporation, will support performance under the contract through its Amerisourcebergen Corporation Division operating as...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $54,620 under an indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is to provide 160 mg/8 ml vials of the chemotherapy drug docetaxel for the period of August 28-29, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency functions to support the resupply needs of the U.S. military...
- The Defense Logistics Agency awarded a $3,632.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561354192, described as 160 mg/16 ml vials of docetaxel in 16 ml quantities. Performance will take place in Conshohocken, Pennsylvania from June 27-28, 2023. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the chemotherapy drug to the Defense Logistics Agency, the logistics combat support agency within the...
- The Defense Logistics Agency awarded a $54,620 delivery order to Amerisourcebergen Drug Corporation for the provision of 4561578979 DOCETAXEL 160 MG/8 ML VIAL 8ML pharmaceutical products. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide chemotherapy drugs in support of DLA and Department of Defense health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding...
- The Defense Logistics Agency awarded a $478,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561527548 DOCETAXEL 160 MG/16 ML VIAL 16ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania under a one day period of performance between July 18-19, 2023. No set aside designation or subcontractors were...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ3KBDelivery Order
The Defense Logistics Agency awarded a $439,260 delivery order to Amerisourcebergen Drug Corporation for the provision of 4561288587, which is described as DOCETAXEL 160 MG/8 ML VIAL 8ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will fulfill the order from its place of performance in Conshohocken, Pennsylvania under firm fixed pricing terms. The delivery order has a period of performance from June 20, 2023 through June 21, 2023 to supply the chemotherapy drug to the DLA, the logistics agency of the Department of Defense, in support of its mission to provide medical supplies and pharmaceuticals to military treatment facilities worldwide. No set aside designation or subcontractors were indicated.
Generated 12/19/23, 11:47 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $439 | 6/20/23 |